Genedx Holdings Corp (WGS)

$104.88 +3.53 (3.48%)
Market Cap 2.93B
Revenue (ttm) 305.45M
Net Income (ttm) -52.29M
EPS (ttm) N/A
PE Ratio 51.72
Forward PE 175.65
Profit Margin -17.12%
Debt to Equity Ratio 0.18
Volume 393,300
Avg Vol 529,868
Day's Range N/A - N/A
Shares Out 28.91M
Stochastic %K 31%
Beta 2.01
Analysts Strong Sell
Price Target $170.89

Company Profile

GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 888 729 1206
Fax: 201 421 2010
Address:
North Tower, 6th Floor 333 Ludlow Street, Stamford, United States
youownitall
youownitall Jan. 27 at 9:47 AM
$WGS It dropped because it was overvalued. It might still be. Would like to see 70’ ish before ER, Shorts pls short more. Thx 🤣
1 · Reply
badger1200
badger1200 Jan. 22 at 7:13 PM
$WGS very disappointed by the performance of late. The decision to announce the small change in projections has wiped a billion and more and it just can’t regain the confidence of the market
1 · Reply
Energy2024
Energy2024 Jan. 21 at 6:53 PM
$WGS 3,-€ All in 😉‼️
0 · Reply
TimisoaraTitans
TimisoaraTitans Jan. 21 at 4:50 AM
$WGS I struggle with the ‘interpretation is the moat’ argument. GeneDx doesn’t own the genomes, doesn’t build the machines, and relies on sequencing done by others. As sequencing costs move well below $100, that layer will only get more competitive. Hard to see what’s truly owned here — and worth watching how much of current profitability reflects timing and accounting rather than durable economics.
1 · Reply
CarverX
CarverX Jan. 20 at 6:56 PM
$WGS Not selling. Time to load up. Just purchased more shares this morning. Good luck to all longs.
0 · Reply
Arcides
Arcides Jan. 20 at 5:28 PM
$WGS already on 100...from 170 to 100 in no while.
0 · Reply
forprofit12
forprofit12 Jan. 20 at 5:04 PM
$WGS added
1 · Reply
CatRocks
CatRocks Jan. 20 at 4:40 PM
$WGS $85.19 gap fill ~Feb 3rd? short bear/Long Bull
0 · Reply
TimisoaraTitans
TimisoaraTitans Jan. 20 at 3:23 PM
$WGS told ya
1 · Reply
Swami2040
Swami2040 Jan. 16 at 6:12 PM
@amitDBA hi Amit, can you post your TA for $WGS when you get a chance. Thanks
0 · Reply
Latest News on WGS
Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

Jan 15, 2026, 11:24 AM EST - 11 days ago

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

GeneDx Holdings Corp. (WGS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 14, 2026, 8:15 PM EST - 12 days ago

GeneDx Holdings Corp. (WGS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

GeneDx: Fundamentals Intact Though Q4 Results Pause Near Term Momentum

Jan 14, 2026, 10:21 AM EST - 13 days ago

GeneDx: Fundamentals Intact Though Q4 Results Pause Near Term Momentum

Why is GeneDx stock crashing on Monday?

Jan 12, 2026, 3:03 PM EST - 14 days ago

Why is GeneDx stock crashing on Monday?

GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance

Jan 12, 2026, 7:30 AM EST - 15 days ago

GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance

GeneDx and Komodo Health Partner to Build the World's Most Complete Longitudinal Rare Disease Dataset

Jan 8, 2026, 8:30 AM EST - 19 days ago

GeneDx and Komodo Health Partner to Build the World's Most Complete Longitudinal Rare Disease Dataset

GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care

Jan 7, 2026, 8:30 AM EST - 20 days ago

GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care

GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care

Jan 6, 2026, 8:30 AM EST - 21 days ago

GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care

GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025

Jan 5, 2026, 8:30 AM EST - 22 days ago

GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025

GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference

Dec 30, 2025, 8:00 AM EST - 4 weeks ago

GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference

JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year

Dec 15, 2025, 8:30 AM EST - 6 weeks ago

JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year

Eight stock picks to play one of the healthiest corners of the market

Dec 11, 2025, 10:37 AM EST - 6 weeks ago

Eight stock picks to play one of the healthiest corners of the market

ALNY ASND INSM MASI NTRA PODD UNH

HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Nov 30, 2025, 3:20 PM EST - 2 months ago

HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

6 Healthcare Stocks With Strong Upward Momentum

Nov 18, 2025, 12:59 PM EST - 2 months ago

6 Healthcare Stocks With Strong Upward Momentum

ABVX CAH ELAN GH MEDP

GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting

Nov 6, 2025, 8:00 AM EST - 2 months ago

GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting

GeneDx to Participate in Upcoming Investor Conferences

Nov 4, 2025, 8:00 AM EST - 3 months ago

GeneDx to Participate in Upcoming Investor Conferences

GeneDx Holdings Corp. (WGS) Q3 2025 Earnings Call Transcript

Oct 28, 2025, 3:41 PM EDT - 3 months ago

GeneDx Holdings Corp. (WGS) Q3 2025 Earnings Call Transcript

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

Oct 28, 2025, 6:30 AM EDT - 3 months ago

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

GeneDx: A Moment Of Reckoning As Market Awaits Q3 Testing Growth

Oct 27, 2025, 8:00 AM EDT - 3 months ago

GeneDx: A Moment Of Reckoning As Market Awaits Q3 Testing Growth

GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims

Oct 27, 2025, 8:00 AM EDT - 3 months ago

GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

Oct 22, 2025, 8:00 AM EDT - 3 months ago

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

Oct 20, 2025, 8:00 AM EDT - 3 months ago

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

GeneDX CEO Katherine Stueland on how the company is using AI to save lives

Oct 15, 2025, 3:30 PM EDT - 3 months ago

GeneDX CEO Katherine Stueland on how the company is using AI to save lives

GeneDX CEO Katherine Stueland on if the cuts at NIH impact the company

Oct 15, 2025, 11:45 AM EDT - 3 months ago

GeneDX CEO Katherine Stueland on if the cuts at NIH impact the company

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

Oct 15, 2025, 9:15 AM EDT - 3 months ago

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

ILMN

GeneDx's Blueprint For The Next Healthcare Revolution

Oct 15, 2025, 2:55 AM EDT - 3 months ago

GeneDx's Blueprint For The Next Healthcare Revolution

How GeneDX CEO Katherine Stueland is using AI to save lives

Oct 14, 2025, 3:17 PM EDT - 3 months ago

How GeneDX CEO Katherine Stueland is using AI to save lives

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

Oct 14, 2025, 8:00 AM EDT - 3 months ago

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

GeneDx to Partner with Florida's Sunshine Genetics Network, Launching Nation's First State-Backed Genomic Newborn Screening Program

Oct 13, 2025, 8:00 AM EDT - 3 months ago

GeneDx to Partner with Florida's Sunshine Genetics Network, Launching Nation's First State-Backed Genomic Newborn Screening Program

GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program

Oct 9, 2025, 8:00 AM EDT - 3 months ago

GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program

GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting

Oct 8, 2025, 8:00 AM EDT - 3 months ago

GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting

GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025

Oct 7, 2025, 8:00 AM EDT - 4 months ago

GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

Oct 1, 2025, 4:01 PM EDT - 4 months ago

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth

Sep 30, 2025, 8:00 AM EDT - 4 months ago

GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth

GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference

Sep 25, 2025, 8:00 AM EDT - 4 months ago

GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference

GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors

Sep 18, 2025, 8:00 AM EDT - 4 months ago

GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors

GeneDx Holdings Corp. (WGS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 10:45 AM EDT - 5 months ago

GeneDx Holdings Corp. (WGS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Seer Appoints Isaac Ro to its Board of Directors

Sep 2, 2025, 7:00 AM EDT - 5 months ago

Seer Appoints Isaac Ro to its Board of Directors

SEER

Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS)

Aug 6, 2025, 9:30 AM EDT - 6 months ago

Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS)

GeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End Growth

Jul 31, 2025, 10:22 AM EDT - 6 months ago

GeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End Growth

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law Group

Jul 31, 2025, 3:30 AM EDT - 6 months ago

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law Group

GeneDx Holdings Corp. Investors: Company Investigated by the Portnoy Law Firm

Jul 30, 2025, 5:07 PM EDT - 6 months ago

GeneDx Holdings Corp. Investors: Company Investigated by the Portnoy Law Firm

GeneDx CEO on rare disease diagnosis: Earlier testing gives families and clinicians more options

Jul 30, 2025, 8:38 AM EDT - 6 months ago

GeneDx CEO on rare disease diagnosis: Earlier testing gives families and clinicians more options

GeneDx Holdings Corp. (WGS) Q2 2025 Earnings Call Transcript

Jul 29, 2025, 5:06 PM EDT - 6 months ago

GeneDx Holdings Corp. (WGS) Q2 2025 Earnings Call Transcript

GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights

Jul 29, 2025, 6:30 AM EDT - 6 months ago

GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law Firm

Jul 28, 2025, 9:43 AM EDT - 6 months ago

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law Firm

youownitall
youownitall Jan. 27 at 9:47 AM
$WGS It dropped because it was overvalued. It might still be. Would like to see 70’ ish before ER, Shorts pls short more. Thx 🤣
1 · Reply
badger1200
badger1200 Jan. 22 at 7:13 PM
$WGS very disappointed by the performance of late. The decision to announce the small change in projections has wiped a billion and more and it just can’t regain the confidence of the market
1 · Reply
Energy2024
Energy2024 Jan. 21 at 6:53 PM
$WGS 3,-€ All in 😉‼️
0 · Reply
TimisoaraTitans
TimisoaraTitans Jan. 21 at 4:50 AM
$WGS I struggle with the ‘interpretation is the moat’ argument. GeneDx doesn’t own the genomes, doesn’t build the machines, and relies on sequencing done by others. As sequencing costs move well below $100, that layer will only get more competitive. Hard to see what’s truly owned here — and worth watching how much of current profitability reflects timing and accounting rather than durable economics.
1 · Reply
CarverX
CarverX Jan. 20 at 6:56 PM
$WGS Not selling. Time to load up. Just purchased more shares this morning. Good luck to all longs.
0 · Reply
Arcides
Arcides Jan. 20 at 5:28 PM
$WGS already on 100...from 170 to 100 in no while.
0 · Reply
forprofit12
forprofit12 Jan. 20 at 5:04 PM
$WGS added
1 · Reply
CatRocks
CatRocks Jan. 20 at 4:40 PM
$WGS $85.19 gap fill ~Feb 3rd? short bear/Long Bull
0 · Reply
TimisoaraTitans
TimisoaraTitans Jan. 20 at 3:23 PM
$WGS told ya
1 · Reply
Swami2040
Swami2040 Jan. 16 at 6:12 PM
@amitDBA hi Amit, can you post your TA for $WGS when you get a chance. Thanks
0 · Reply
PhishTourFunds
PhishTourFunds Jan. 16 at 3:50 AM
$WGS I’m not into exact lines (obv) but we got a Wyckoff here along with a break below the 200MA and an RSI under 25. Shiiiiiiiiiiiiiiit 🔥
1 · Reply
nucleotied
nucleotied Jan. 15 at 5:03 PM
$WGS Small ASP erosion means larger non-trivial volume makeup needed to hit rev targets
0 · Reply
nucleotied
nucleotied Jan. 15 at 4:58 PM
$WGS they lose a smidge of reimbursement $$ levels and they have to make it up in volume. Seems like it’s a tepid forecast and worse on a razors edge.
0 · Reply
nucleotied
nucleotied Jan. 15 at 4:54 PM
$WGS answered my own question. NO ASP erosion.
0 · Reply
PencilNeckGeek
PencilNeckGeek Jan. 15 at 4:42 PM
$WGS Would be nice to see a close back over the 200ma
0 · Reply
v92
v92 Jan. 14 at 9:09 PM
$WGS this is trading way out of wack with peer multiples. This has a long way to go down. Long. Way.
1 · Reply
CatRocks
CatRocks Jan. 14 at 8:13 PM
$WGS It's pushing down. Heading for the 85.19 gap fill. It has a couple of minor supports to get through first.
0 · Reply
11thestate
11thestate Jan. 14 at 1:29 PM
$WGS is now accepting claims for a 21M settlement it is paying to investors over claims that it misled shareholders in connection with its 2021 de-SPAC merger. Even if you missed the deadline, if you bought $WGS between July 19, 2021 and July 22, 2021, you still can file for payment here: https://11th.com/cases/cmls-investor-settlement
0 · Reply
youownitall
youownitall Jan. 14 at 8:55 AM
$WGS $90 I’ll consider
0 · Reply
Boring_Kitty
Boring_Kitty Jan. 13 at 9:33 PM
$WGS This is done for now
0 · Reply
CarverX
CarverX Jan. 13 at 9:10 PM
$WGS Added more shares today and will be adding more next week 🚀🚀🚀
0 · Reply
PencilNeckGeek
PencilNeckGeek Jan. 13 at 9:09 PM
$WGS Closed right on the 200ma
0 · Reply